期刊文献+

环氧合酶2基因在大鼠脑缺血再灌注损伤中的表达及意义 被引量:1

The Expression and Significance of Cyclooxygenase-2 in Ischemic Reperfusion Injury of Middle Cerebral Artery in Rats
下载PDF
导出
摘要 目的探讨局灶性脑缺血再灌注损伤过程中环氧合酶2基因的表达及其意义。方法采用栓线法制备大鼠大脑中动脉缺血再灌注损伤模型。随机分为8组:假手术组,缺血2h组,缺血再灌注3h、6h、12h、24h、48h、72h组,每组10只。评定神经功能损伤,HE染色观察脑组织形态学改变。Northern blot、Western blot和免疫组织化学染色方法检测脑组织环氧合酶2 mRNA和蛋白产物表达。结果神经功能缺损表现随缺血再灌注时间的延长而逐渐加重。缺血2h组环氧合酶2 mRNA和蛋白产物表达比假手术组明显增加(P<0.01),再灌注后表达逐渐增强,再灌注12h环氧合酶2的mRNA表达达高峰(0.92±0.30),再灌注24h环氧合酶2的蛋白产物表达达高峰(0.72±0.18),与其它组比较差异有显著性(P<0.01)。结论环氧合酶2基因在局灶性脑缺血再灌注损伤中的表达呈动态变化过程,环氧合酶2可能与缺血再灌注后迟发性神经细胞死亡有关。 Aim To explore the expression and significance of cyclooxygenase (COX-2) during the focal ischemic reperfusion injury of middle cerebral artery in rats. Methods The model of focal ischemic reperfusion injury of middle cerebral artery was built in rats by placing an intraluminal suture. 80 rats were divided into 8 groups, which were control group, ischemia for 2 hours, ischemic reperfusion for 3 hours, 6 hours, 12 hours, 24 hours, 48 hours, 72 hours. The nerve function was evaluated and the change of brain tissue injury was observed by HE stain. Northern blot, Western blot and immunohistochemistry were used to dectect the expression of COX-2. Results Manifestation of neurologic impairment gradually aggravated with the extension of reperfusion time. The mRNA and protein expression of COX-2 increased significantly after ischemia for 2 hours, and gradually reinforced after repeffusion, which reached the peak from 12 hours to 24 hours after reperfusion ( P 〈 0.01 ). Conculsion The expression of COX-2 gene in focal cerebral isehemia reperfusion injury was dynamic changing process. The expression of COX-2 protein may be involved in the delayed neuronal death after ischemic reperfusion injury.
出处 《中国动脉硬化杂志》 CAS CSCD 2007年第5期321-324,共4页 Chinese Journal of Arteriosclerosis
基金 国家自然科学基金(30600631) 辽宁省教育厅高等学校科研项目(05L485)
关键词 神经病学 环氧合酶 局灶性脑缺血 再灌注损伤 大鼠 Cyclooxygenase Focal cerebral isehemia Reperfusion injury Rat
  • 相关文献

参考文献7

  • 1williams CS, Dubois RN. Prostaglandin endoperoxide synthase: why two isoforms [J]. Am J Physiol, 1996, 270 (3pt1) : G393-400.
  • 2陈琳,匡希斌.异构前列腺素与临床氧化应激性损伤疾病[J].中国动脉硬化杂志,2005,13(5):667-669. 被引量:13
  • 3Longa EZ, Weinstein PR, Carlson S, Cummmins R. Reversible middle cerebral artery occlusion without craniectomy in rats [J]. Stroke, 1989, 20(1): 84-91.
  • 4Sambrook J.Fritsch EF,Maniatis T.克隆化基因所表达蛋白质的检测与分析[M].金冬雁,黎孟枫,译.分子克隆实验指南(第二版).北京:科学出版社,1992;363-371.
  • 5Nogawa S, Zhang F, Ross ME, Iadecola C. Cyclooxygenase-2 gene expression in neurons contributes to ischemic brain damage [J]. J Neurosci, 1997, 17 (12) : 2746-755.
  • 6Kinouchi H, Huang H, Arai S, Mizoi K, Yoshimoto T. Induction of cyclooxy genase-2 messenger RNA after transient and permanent middle cerebral artery occlusion in rats: comparison with c-fos messenger RNA by using in situ lrybridization [J]. J Neurosurg, 1999, 91 (6): 1005-012.
  • 7Hewett SJ, Vliasz TF, Vidwans AS, Hewett JA. Cyclooxygenase-2 contaibutes to N-methyl-D-aspartate mediated neuronal cell death ia primary cortical cell culture [J]. J Pharmacol Exp Ther, 2000, 293 (2): 417-425.

二级参考文献20

  • 1Yin H, Havrilla CM, Gao L, Morrow JD, Porter NA. Mechanisms for the formation of isoprostane endoperoxides from arachidonic acid. J Biol Chem, 2003, 278 (19): 16 720-725.
  • 2Roberts II LJ, Montine TJ, Markesbery WR, Tapper AR, Pierre Hardy, Sylvain Chemtob, et al. Formation of isoprostane-like compounds (Neuroprostanes) in Vivo from docosahexaenoic acid. J Biol Chem, 1998, 273 (22): 13 605-612.
  • 3Carlo Patrono, FitzGerald GA. Isoprostanes: Potential markers of oxidant stress in atherothrombotic disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 1997, 17 (11): 2 309-315.
  • 4Weber TJ, Markillie LM. Regulation of activator protein-1 by 8-iso-prostaglandin E2 in a thromboxane A2 receptor-dependent and independent. Molecular Pharmacology, 2003, 63 (5): 1 075-081.
  • 5Domenico Pratico, Lawson JA, FitzGerald GA. Cylooxygenase-dependent formation of the isoprostane, 8-epi prostaglandin F. Biochemistry and Molecular Biology, 1995, 270 (17): 9 800-808.
  • 6O'Donnell VB, Freeman BA. Interactions between nitric oxide and lipid oxidation pathways-implications for vascular disease. Circ Res, 2001, 88 (1): 12-21.
  • 7Scholz H, Yndestad A, Damas JK, Waehre T, Tonstad S, Aukrust P, et al. 8-Isoprostane increases expression of interleukin-8 in human macrophages through activation of mitogen-activated protein kinases. Cardiovascular Research, 2003, 59 (4): 945-954.
  • 8Audoly LP, Rocca B, Fabre JE, Koller BH, Thomas D, Loeb AL, et al. Cardiovascular responses to the isoprostanes iPF (2alpha)-III and iPE (2)-III are mediated via the thromboxane A(2) receptor in vivo. Circulation, 2000, 101 (24): 2 833-840.
  • 9Reilly MP, Delanty N, Roy L, Rokach J, Callaghan PO, Crean P, Lawson JA. Increased formation of the isoprostanes IPF2 -I and 8-Epi-prostaglandin F2 in acute coronary angioplasty evidence for oxidant stress during coronary reperfusion in humans. Circulation, 1997, 96 (10): 3 314-320.
  • 10Haas JA, Krier JD, Bolterman RJ, Juncos LA, Romero JC. Low-dose angiotensin Ⅱ increases free isoprostane levels in plasma. Hypertension, 1999, 34 (4Pt2): 983-986.

共引文献12

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部